Literature DB >> 11246328

Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: report on three cases.

W Scheppach1, G Druge, G Wittenberg, J G Mueller, A M Gassel, H J Gassel, F Richter.   

Abstract

OBJECTIVE: To describe three unusual cases of sclerosing cholangitis after severe extrahepatic/extrabiliary bacterial infections.
DESIGN: Case report, clinical.
SETTING: Tertiary care intensive care unit (ICU). PATIENTS: Three patients admitted to the ICU with infections from Gram-positive bacteria followed by sclerosing cholangitis and secondary biliary cirrhosis. MAIN
RESULTS: Three unusual cases of persisting cholestasis that occurred after bacterial infections originating from extrahepatic/extrabiliary foci are described. Endoscopic retrograde cholangiopancreatography and magnetic resonance cholangiopancreatography revealed multiple strictures of the intrahepatic bile ducts as a sign of sclerosing cholangitis. All patients progressed to biliary cirrhosis within months after the onset of cholestasis.
CONCLUSION: Infection-associated cholestasis is usually a functional disorder and subsides after effective treatment of the underlying inflammatory focus. In rare cases, however, extrahepatic/extrabiliary infections may lead to sclerosing cholangitis and secondary biliary cirrhosis via unknown mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246328     DOI: 10.1097/00003246-200102000-00042

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  17 in total

1.  Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis.

Authors:  Irene Esposito; Andrea Kubisova; Adolf Stiehl; Hasan Kulaksiz; Peter Schirmacher
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

2.  [Secondary sclerosing cholangitis after multiple trauma and long-term intensive care treatment: case report of a characteristic course].

Authors:  M Seemann; G Kirchner; S Bele; B Sinner; B Graf; M Kieninger
Journal:  Anaesthesist       Date:  2013-01-24       Impact factor: 1.041

3.  Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience.

Authors:  Ting Lin; Kai Qu; Xinsen Xu; Min Tian; Jie Gao; Chun Zhang; Ying Di; Yuelang Zhang; Chang Liu
Journal:  Front Med       Date:  2014-01-10       Impact factor: 4.592

4.  Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms.

Authors:  Johannes Benninger; Rainer Grobholz; Yurdaguel Oeztuerk; Christoph H Antoni; Eckhart G Hahn; Manfred V Singer; Richard Strauss
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

Review 5.  Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.

Authors:  Pedro Martins; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2019-07-30

Review 6.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

7.  Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders.

Authors:  S Engler; C Elsing; C Flechtenmacher; L Theilmann; W Stremmel; A Stiehl
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 8.  Biliary cast formation with sclerosing cholangitis in critically ill patient: case report and literature review.

Authors:  O-nyoung Kwon; Seung Hyun Cho; Chang Keun Park; Sung Hee Mun
Journal:  Korean J Radiol       Date:  2012-04-17       Impact factor: 3.500

9.  Klatskin-like lesions.

Authors:  M P Senthil Kumar; R Marudanayagam
Journal:  HPB Surg       Date:  2012-06-28

10.  Abdominal obesity and prolonged prone positioning increase risk of developing sclerosing cholangitis in critically ill patients with influenza A-associated ARDS.

Authors:  Thomas Weig; Mirjam I Schubert; Norbert Gruener; Michael E Dolch; Lorenz Frey; Jens Miller; Thorsten Johnson; Michael Irlbeck
Journal:  Eur J Med Res       Date:  2012-12-22       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.